CEM Contract Win 7th May7 May 2026 07:30
And of course the positive here is that Simon during the fundraise was talking up CEM for its possibility to move into defence and healthcare. As he is quoted in the Shore note this AM "we continue to re-position the CEM division into key high-margin growth markets including defence, medical and healthcare." So, I'd be interested to see how this contract looks margin wise, and expect it to be accretive to the 5% operating margin which is in the numbers for FY26. 9.1% is forecast at op margin level for FY27 and the increase in higher margin contracts in these new sectors is definitely a key driver for that, so it's good to see it coming early here. Again from Shore's note "we believe that we have been conservative in both our revenue and margin forecasts in FY26F and future years, especially if greater sales traction is achieved in the defence and healthcare markets."
By the by, CEM is now, of course, including the building, fully owned by LST after some of the fundraise proceeds were used to buy the remaining 10% of the business. We figured it was worth around £4m conservatively (pretty much just the assets and building itself), but adding in some higher margin revenue lines and contracts would surely only expand the multiple and make that division a very strong underpin of the c£20m mkt cap post raise. The rationale for buuying the 10% was to allow CEM / LST to make the upgrades to the building needed in servicing more clients in healthcare and defence markets, so having this contract now is certainly proof that it is working!
NB: Talking up my own book as we are significant and declarable holders here, as usual DYOR, NOT financial advice.